Operationalizing the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Cancer Prevention Recommendations: A Standardized Scoring System.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
12 Jul 2019
Historique:
received: 29 05 2019
revised: 10 07 2019
accepted: 10 07 2019
entrez: 25 7 2019
pubmed: 25 7 2019
medline: 23 1 2020
Statut: epublish

Résumé

Following the publication of the 2018 World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) Third Expert Report, a collaborative group was formed to develop a standardized scoring system and provide guidance for research applications. The 2018 WCRF/AICR Cancer Prevention Recommendations, goals, and statements of advice were examined to define components of the new Score. Cut-points for scoring were based on quantitative guidance in the 2018 Recommendations and other guidelines, past research that operationalized 2007 WCRF/AICR Recommendations, and advice from the Continuous Update Project Expert Panel. Eight of the ten 2018 WCRF/AICR Recommendations concerning weight, physical activity, diet, and breastfeeding (optional), were selected for inclusion. Each component is worth one point: 1, 0.5, and 0 points for fully, partially, and not meeting each recommendation, respectively (Score: 0 to 7-8 points). Two recommendations on dietary supplement use and for cancer survivors are not included due to operational redundancy. Additional guidance stresses the importance of accounting for other risk factors (e.g., smoking) in relevant models. The proposed 2018 WCRF/AICR Score is a practical tool for researchers to examine how adherence to the 2018 WCRF/AICR Recommendations relates to cancer risk and mortality in various adult populations.

Sections du résumé

BACKGROUND BACKGROUND
Following the publication of the 2018 World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) Third Expert Report, a collaborative group was formed to develop a standardized scoring system and provide guidance for research applications.
METHODS METHODS
The 2018 WCRF/AICR Cancer Prevention Recommendations, goals, and statements of advice were examined to define components of the new Score. Cut-points for scoring were based on quantitative guidance in the 2018 Recommendations and other guidelines, past research that operationalized 2007 WCRF/AICR Recommendations, and advice from the Continuous Update Project Expert Panel.
RESULTS RESULTS
Eight of the ten 2018 WCRF/AICR Recommendations concerning weight, physical activity, diet, and breastfeeding (optional), were selected for inclusion. Each component is worth one point: 1, 0.5, and 0 points for fully, partially, and not meeting each recommendation, respectively (Score: 0 to 7-8 points). Two recommendations on dietary supplement use and for cancer survivors are not included due to operational redundancy. Additional guidance stresses the importance of accounting for other risk factors (e.g., smoking) in relevant models.
CONCLUSIONS CONCLUSIONS
The proposed 2018 WCRF/AICR Score is a practical tool for researchers to examine how adherence to the 2018 WCRF/AICR Recommendations relates to cancer risk and mortality in various adult populations.

Identifiants

pubmed: 31336836
pii: nu11071572
doi: 10.3390/nu11071572
pmc: PMC6682977
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Public Health Nutr. 2011 Jan;14(1):5-13
pubmed: 21211100
Am J Clin Nutr. 2012 Jul;96(1):150-63
pubmed: 22592101
Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):792-802
pubmed: 23462914
Am J Clin Nutr. 2013 May;97(5):1107-20
pubmed: 23553166
Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1498-508
pubmed: 23780838
Nutr Cancer. 2013;65(5):633-43
pubmed: 23859030
Cancer Causes Control. 2014 May;25(5):541-52
pubmed: 24557428
Int J Cancer. 2014 Nov 15;135(10):2444-52
pubmed: 24723234
Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2066-77
pubmed: 25017249
Cancer Causes Control. 2015 Feb;26(2):277-286
pubmed: 25559553
Public Health Nutr. 2015 Dec;18(18):3337-48
pubmed: 25805146
BMC Med. 2015 May 07;13:107
pubmed: 25948112
PLoS One. 2015 May 15;10(5):e0126096
pubmed: 25978407
Cancer Epidemiol. 2016 Feb;40:15-21
pubmed: 26605429
Int J Cancer. 2016 Jun 1;138(11):2602-15
pubmed: 26756307
Int J Cancer. 2016 Jun 1;138(11):2657-64
pubmed: 26804371
BMJ Open. 2016 Mar 09;6(3):e009892
pubmed: 26962035
JAMA Intern Med. 2016 Jun 1;176(6):816-25
pubmed: 27183032
Cancer Causes Control. 2016 Jul;27(7):869-79
pubmed: 27220873
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1018-28
pubmed: 27340121
Am J Clin Nutr. 2016 Sep;104(3):678-85
pubmed: 27488239
Int J Cancer. 2016 Dec 15;139(12):2738-2752
pubmed: 27578546
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):136-144
pubmed: 27793797
Appetite. 2017 Jan 1;108:512-520
pubmed: 27825941
Popul Health Metr. 2017 Feb 14;15(1):6
pubmed: 28193285
Eur J Cancer. 2017 Nov;85:86-94
pubmed: 28892777

Auteurs

Marissa M Shams-White (MM)

Risk Factor Assessment Branch, Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892, USA. marissa.shams-white@nih.gov.

Nigel T Brockton (NT)

American Institute for Cancer Research, Arlington, VA 22209, USA.

Panagiota Mitrou (P)

World Cancer Research Fund International, 22 Bedford Square, London, WC1B 3HH, UK.

Dora Romaguera (D)

Balearic Islands Health Research Institute (IdISBa), University Hospital Son Espases, 07120 Palma de Mallorca, Spain.
Barcelona Institute for Global Health (ISGlobal), 08003 Barcelona, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), 28029 Madrid, Spain.

Susannah Brown (S)

World Cancer Research Fund International, 22 Bedford Square, London, WC1B 3HH, UK.

Alice Bender (A)

American Institute for Cancer Research, Arlington, VA 22209, USA.

Lisa L Kahle (LL)

Information Management Services, Inc., Rockville, MD 20850, USA.

Jill Reedy (J)

Risk Factor Assessment Branch, Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH